Compare ENGN & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ENGN | MHN |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 293.6M |
| IPO Year | N/A | N/A |
| Metric | ENGN | MHN |
|---|---|---|
| Price | $7.80 | $10.25 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $22.71 | N/A |
| AVG Volume (30 Days) | ★ 437.5K | 59.2K |
| Earning Date | 12-19-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.65 | $8.69 |
| 52 Week High | $11.14 | $10.81 |
| Indicator | ENGN | MHN |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 44.16 |
| Support Level | $8.05 | $10.25 |
| Resistance Level | $9.14 | $10.32 |
| Average True Range (ATR) | 0.60 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 16.88 | 3.64 |
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.